83 related articles for article (PubMed ID: 26195480)
1. Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study.
van Ballegooijen AJ; Gansevoort RT; Lambers-Heerspink HJ; de Zeeuw D; Visser M; Brouwer IA; Kema IP; de Borst MH; Bakker SJ; Joosten MM
Hypertension; 2015 Sep; 66(3):563-70. PubMed ID: 26195480
[TBL] [Abstract][Full Text] [Related]
2. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study.
Joosten MM; Gansevoort RT; Mukamal KJ; Kootstra-Ros JE; Feskens EJ; Geleijnse JM; Navis G; Bakker SJ;
Hypertension; 2013 Jun; 61(6):1161-7. PubMed ID: 23608650
[TBL] [Abstract][Full Text] [Related]
3. Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study.
Kieneker LM; Gansevoort RT; Mukamal KJ; de Boer RA; Navis G; Bakker SJ; Joosten MM
Hypertension; 2014 Oct; 64(4):769-76. PubMed ID: 25047575
[TBL] [Abstract][Full Text] [Related]
4. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis).
van Ballegooijen AJ; Kestenbaum B; Sachs MC; de Boer IH; Siscovick DS; Hoofnagle AN; Ix JH; Visser M; Brouwer IA
J Am Coll Cardiol; 2014 Apr; 63(12):1214-1222. PubMed ID: 24480627
[TBL] [Abstract][Full Text] [Related]
5. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
[TBL] [Abstract][Full Text] [Related]
6. Joint Association of Low Vitamin D and Vitamin K Status With Blood Pressure and Hypertension.
van Ballegooijen AJ; Cepelis A; Visser M; Brouwer IA; van Schoor NM; Beulens JW
Hypertension; 2017 Jun; 69(6):1165-1172. PubMed ID: 28396533
[TBL] [Abstract][Full Text] [Related]
7. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.
Forman JP; Giovannucci E; Holmes MD; Bischoff-Ferrari HA; Tworoger SS; Willett WC; Curhan GC
Hypertension; 2007 May; 49(5):1063-9. PubMed ID: 17372031
[TBL] [Abstract][Full Text] [Related]
8. Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach.
Kunutsor SK; Kieneker LM; Burgess S; Bakker SJL; Dullaart RPF
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133521
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension.
Jorde R; Figenschau Y; Emaus N; Hutchinson M; Grimnes G
Hypertension; 2010 Mar; 55(3):792-8. PubMed ID: 20065152
[TBL] [Abstract][Full Text] [Related]
10. Circulating vitamin D metabolites and kidney disease in type 1 diabetes.
de Boer IH; Sachs MC; Cleary PA; Hoofnagle AN; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD;
J Clin Endocrinol Metab; 2012 Dec; 97(12):4780-8. PubMed ID: 22990096
[TBL] [Abstract][Full Text] [Related]
11. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women.
Forman JP; Curhan GC; Taylor EN
Hypertension; 2008 Nov; 52(5):828-32. PubMed ID: 18838623
[TBL] [Abstract][Full Text] [Related]
12. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
Skaaby T
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and hypertension: Prospective study and meta-analysis.
Qi D; Nie XL; Wu S; Cai J
PLoS One; 2017; 12(3):e0174298. PubMed ID: 28358827
[TBL] [Abstract][Full Text] [Related]
14. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.
Dobnig H; Pilz S; Scharnagl H; Renner W; Seelhorst U; Wellnitz B; Kinkeldei J; Boehm BO; Weihrauch G; Maerz W
Arch Intern Med; 2008 Jun; 168(12):1340-9. PubMed ID: 18574092
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population.
Skaaby T; Husemoen LL; Pisinger C; Jørgensen T; Thuesen BH; Fenger M; Linneberg A
Cardiology; 2012; 123(1):62-70. PubMed ID: 22986625
[TBL] [Abstract][Full Text] [Related]
16. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D Levels in Pediatric Intensive Care Units: Risk Factors and Association With Clinical Course.
McNally JD; Menon K; Lawson ML; Williams K; Doherty DR
J Clin Endocrinol Metab; 2015 Aug; 100(8):2942-5. PubMed ID: 26052726
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of vitamin D₃, 25-hydroxyvitamin D₃ and 24,25-dihydroxyvitamin D₃ in human serum by LC-MS/MS.
Burild A; Frandsen HL; Jakobsen J
Scand J Clin Lab Invest; 2014 Aug; 74(5):418-23. PubMed ID: 24749986
[TBL] [Abstract][Full Text] [Related]
19. High parathyroid hormone, but not low vitamin D concentrations, expose elderly inpatients to hypertension.
Mateus-Hamdan L; Beauchet O; Bouvard B; Legrand E; Fantino B; Annweiler C
Geriatr Gerontol Int; 2013 Jul; 13(3):783-91. PubMed ID: 22994947
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial.
Arora P; Song Y; Dusek J; Plotnikoff G; Sabatine MS; Cheng S; Valcour A; Swales H; Taylor B; Carney E; Guanaga D; Young JR; Karol C; Torre M; Azzahir A; Strachan SM; O'Neill DC; Wolf M; Harrell F; Newton-Cheh C; Wang TJ
Circulation; 2015 Jan; 131(3):254-62. PubMed ID: 25359163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
